BioMidwest

Found 78,251 articles

• Marrow Access Technologies Announces US Market Release of Novel Cartilage Repair Solution for Ankle

  3/22/2023

  Marrow Access Technologies announced the full US market release of its newest advancement of the SmartShot marrow access device, designed specifically to address the unique needs of ankle joint preservation.

• Journey Medical Corporation to Announce Year End 2022 Financial Results on March 29, 2023Company to host conference call to discuss financial results and provide a corporate update on March 29, 2023 at 4:30 p.m. ET

  3/22/2023

  Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions, announced the Company will release its year end 2022 financial results after the U.S. financial markets close on Wednesday, March 29, 2023.

• AmbioPharm to Host a Sustainable Peptide Manufacturing Workshop at Biologics 2023

  3/22/2023

  AmbioPharm, a worldwide leader in peptide API CDMO services, to host a workshop on sustainable peptide manufacturing at Biologics 2023 taking place in London, UK on March 29, 2023.

• Medexus Announces New License Deal for Topical Terbinafine

  3/22/2023

  Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that the company has secured Canadian rights to commercialize terbinafine hydrochloride nail lacquer supplied by Polichem, an Almirall group company focused on medical dermatological treatments for skin health.

• CONMED Corporation Announces Annual Meeting of Stockholders - March 22, 2023

  3/22/2023

  CONMED Corporation announced that its Annual Meeting of Stockholders will be held on Wednesday, May 24, 2023, at 1:30 p.m. ET at its corporate headquarters at 11311 Concept Boulevard, Largo FL and through the internet virtually.

• Panbela Announces Issuance of New Patent in Japan; Patent is for Claims of a Novel Process for the Production of SBP-101

  3/22/2023

  Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced an Issue Notification for patent JP 7232845 titled “METHODS FOR PRODUCING (6S,15S)-3,8,13,18- TETRAAZAICOSANE-6,15-DIOL”.

• Infinity Laboratories Announces Hiring of New Senior Vice President of Commercial Operations

  3/22/2023

  Infinity Laboratories is proud to announce the hiring of Hank Nowak as our new Senior Vice President of Commercial Operations.

• Leading Diabetes Researcher Speaks on his Groundbreaking ‘Edmonton Protocol’ with CancerVAX CEO Ryan Davies

  3/22/2023

  CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that will use the body’s immune system to fight cancer, announced that CEO Ryan Davies spoke with world-renown diabetes researcher Dr. Jonathan Lakey.

• Vanqua Bio to Present at the Stifel 2023 CNS Day Conference

  3/22/2023

  Vanqua Bio announced today that the company will participate in the Stifel 2023 CNS Day Conference, which is being held virtually March 28-29.

• Acumen Pharmaceuticals to Participate in Stifel 2023 Virtual CNS Days

  3/22/2023

  Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced today that management will participate in a fireside chat at the Stifel 2023 Virtual CNS Days on Wednesday, March 29, 2023 at 12:30 p.m. ET.

• Xentria Announces Peer Reviewed Publication of Biosimulation Model in Frontiers in Pharmacology Journal

  3/21/2023

  Xentria Announces Peer Reviewed Publication of Biosimulation Model in Frontiers in Pharmacology Journal.

• Wugen Announces CEO Transition

  3/21/2023

  Wugen, Inc. today announced that Kumar Srinivasan Ph.D., M.B.A., has been appointed President and Chief Executive Officer, effective March 13, 2023.

• Brainomix Receives FDA Clearance for Its Flagship Stroke AI Imaging Software

  3/21/2023

  Brainomix today announced that its Brainomix 360 e-ASPECTS tool for stroke has received FDA clearance, enabling the Oxford-based company to deploy its cutting-edge stroke AI imaging platform to US stroke centers.

• OcuSciences Announces Publication Showing Potential to Detect Retinal Diseases with High Sensitivity

  3/21/2023

  OcuSciences today announced a publication in Frontiers in Ophthalmology journal.

• Surgalign Schedules Fourth Quarter and Full Year 2022 Earnings Release for March 30, 2023

  3/21/2023

  Surgalign Holdings, Inc. today announced its plans to release financial results for its fourth quarter and full year 2022 after the close of trading on March 30, 2023.

• Aviv Clinics Highlights New Hyperbaric Oxygen Therapy Study Bringing Hope to Fibromyalgia Patients

  3/21/2023

  Aviv Clinics is sharing the results of a new study that shows hyperbaric oxygen therapy is more effective than pharmaceutical treatment in fibromyalgia patients following traumatic brain injury.

• Inspired Spine Pushes Medical Boundaries with Second International Trip in 2023

  3/21/2023

  Inspired Spine, a leader in minimally invasive spine surgery, is once again transcending medical borders.

• Zynex Included in Denver-Area's Top 10 Biotechnology/Bioscience Companies

  3/21/2023

  Zynex, Inc. announced the Denver Business Journal has ranked Zynex sixth in a list of the largest Denver-area Biotechnology/Bioscience companies, according to the number of full-time employees.

• Co-Diagnostics, Inc. to CEO to Deliver Keynote Address at 2023 MarketsandMarkets Conference in London, England

  3/21/2023

  Co-Diagnostics, Inc. announced that the Company CEO will deliver the keynote address at the 4th Annual MarketsandMarkets Infectious Disease Diagnostics and Molecular Diagnostics Conference, held March 23-24, 2023, in London, England, where the Company will also be hosting a booth.

• New American Lung Association Research Institute to Accelerate High Impact, Lifesaving Lung Health Science

  3/21/2023

  More than 34 million Americans live with lung disease. When combined with lung cancer and respiratory diseases like COVID-19 and influenza, lung disease is a leading cause of death in America.